|

Talazoparib with enzalutamide Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Talzenna, Xtandi

Pipeline

Phase 2: 1

Top Sponsors

  • Prostate Cancer Clinical Trials Consortium1

Indications

  • mCRPC (Metastatic Castration-resistant Prostate Cancer)1
  • Prostate Cancer (Adenocarcinoma)1
  • Cancer1

Boston, Massachusetts1 trial

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate

Dana Farber Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.